SEPTInvestingStart Free

MDCX 424B3: Secondary offering

Medicus Pharma Ltd.

Filed with the SEC on · accession 0001062993-26-004910

MDCX filed a 424B3 (prospectus (offering)) with the SEC on Sep 14, 2026. The final terms of an offering of shares or bonds. The stock moved -2.0% by the first close after the filing.

Summary of the filing

Medicus Pharma Ltd. filed a prospectus supplement to register 3,245,595 common shares issuable upon exercise of warrants, and disclosed the issuance of 8,529,412 restricted common shares to officers and employees in lieu of cash bonuses.

For details, click here →How to read a 424B3 →

Key details

Cash bonuses awarded and converted to restricted shares$1.4M
Restricted common shares issuedshares 8.5M
Common shares issuable upon exercise of warrantsshares 3.2M
IssuerMedicus Pharma Ltd.
Executive chairman and chief executive officerRaza Bokhari

How MDCX stock reacted

Close before

$8.13

Sep 11, 2026

First close after

-2.03%

$7.96

5 trading days

+4.74%

$8.52

Since filing

-77.00%

$1.87

✦ Ask GOAX AI about this filing — what it means for MDCX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MDCX?

Click here

Frequently asked questions

What did MDCX file with the SEC on Sep 14, 2026?

MDCX filed a 424B3 (Secondary offering). Medicus Pharma Ltd. filed a prospectus supplement to register 3,245,595 common shares issuable upon exercise of warrants, and disclosed the issuance of 8,529,412 restricted common shares to officers and employees in lieu of cash bonuses.

What does a secondary offering mean for MDCX stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 424B3?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did MDCX stock react to this filing?

MDCX closed at $8.13 before the filing and $7.96 on Sep 14, 2026 (-2.03%). Five trading days later: $8.52 (+4.74%).

Other MDCX SEC filings

Get alerts when MDCX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
MDCX overviewMDCX analysisMDCX newsLatest SEC filings